75A50124F61011↗
Seqirus Inc received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $23.7K obligated so far for drugs and biologicals. Its period of performance ended 2025-03-14.
Key facts · data as of Oct 21, 2026
- Recipient
- Seqirus Inc
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $23.7K
- Potential value
- $23.7K
- Ends
- 2025-03-14
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 21, 2026.
Cite this page: SpendQuery, Award 75A50124F61011, data as of Oct 21, 2026, https://spendquery.com/award?id=CONT_AWD_75A50124F61011_7505_75A50122D00004_7505
Seqirus Inc: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT OF THE INTENDED HOLD TIME FOR THE BARDA SPONSORED BPI-23-001 STUDY.
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75A50122D00004
- Where the work is
- Wake, NC · district NC-13
- Funding law
- COVID-19 laws
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
3 actions since 2024-09-19. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-25 | P00002 | Close-out | $0 | THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT OF THE INTENDED HOLD TIME FOR THE BARDA SPONSORED BPI-23-001 STUDY. |
| 2024-11-22 | P00001 | Administrative change | $0 | THE PURPOSE OF THIS NO COST BILATERAL MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM DECEMBER 3, 2024 TO MARCH 14, 2025. |
| 2024-09-19 | 0 | $23.7K | THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT OF THE INTENDED HOLD TIME FOR THE BARDA SPONSORED BPI-23-001 STUDY. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-21). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗